Paid Clinical Trials Billings

Discover 143 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 143

Saruparib

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Billings MT, Bozeman MT, Salt Lake City UT, Spokane Valley WAshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Amivantamab-Subcutaneous

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Billings MT, Bozeman MT, Great Falls MT, Missoula MTshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Inotuzumab Ozogamicin & Chemotherapy

Recruiting

PHASE2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Billings MT, Bozeman MT, Great Falls MT, Anaconda MTshow 57 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Apalutamide with Hormone Therapy

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Billings MT, Great Falls MT, Sioux Falls SD, Willmar MNshow 232 more

Code:

NCT04134260

Conditions

Prostate Adenocarcinoma

Stage I Prostate Cancer AJCC v8

Stage II Prostate Cancer AJCC v8

Stage IIA Prostate Cancer AJCC v8

Stage IIB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apalutamide

Hormone Therapy

Quality-of-Life Assessment

Questionnaire Administration

Radiation Therapy

Lomustine with Temozolomide & Radiation

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Billings MT, Bozeman MT, Rapid City SD, Logan UTshow 262 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

V940 vs. Pembrolizumab

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Billings MT, Post Falls ID, Colorado Springs CO, Grand Forks NDshow 34 more

Code:

NCT06077760

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

V940

Pembrolizumab

Placebo

INBRX-106 & Pembrolizumab

Recruiting

PHASE2

PHASE3

Sponsor:

Inhibrx Biosciences, Inc

Location:

Billings MT, Omaha NE, Santa Fe NM, Sacramento CAshow 10 more

Code:

NCT06295731

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106

Pembrolizumab

MK-1084 & Pembrolizumab

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Billings MT, Madison WI, Beverly Hills CA, Skokie ILshow 4 more

Code:

NCT06345729

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-1084

Placebo

Pembrolizumab

Neratinib & Palbociclib

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Billings MT, Bozeman MT, Great Falls MT, Anaconda MTshow 100 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Zanubrutinib & Anti-CD20

Recruiting

PHASE3

Sponsor:

BeiGene

Location:

Billings MT, Spokane WA, Saskatoon, Watertown SDshow 61 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab